IBS is diagnosed primarily through your symptom pattern, not a single test. There’s no blood draw, scan, or biopsy that confirms it outright. Instead, doctors use a standardized set of criteria based on how often you have abdominal pain, how long it’s been happening, and whether that pain relates to changes in your bowel habits. The process also involves ruling out a short list of conditions that can mimic IBS.
The Rome IV Criteria
The current standard for diagnosing IBS is called the Rome IV criteria. To meet the threshold, you need recurrent abdominal pain averaging at least one day per week over the past three months, and that pain must be linked to at least two of the following: it’s related to having a bowel movement, it comes with a change in how often you go, or it comes with a change in stool consistency (harder, looser, or both).
There’s also a lookback requirement. Your symptoms need to have started at least six months before the diagnosis is made, even though the criteria only require the pattern to be present during the most recent three months. This time window helps distinguish IBS from a temporary stomach bug or a brief stress-related episode.
How Subtypes Are Classified
Once the diagnosis is established, your doctor will classify it into a subtype based on what your stool typically looks like. This matters because treatments differ depending on whether constipation or diarrhea is your dominant problem. The Bristol Stool Scale, a visual chart that grades stool from type 1 (hard lumps) to type 7 (entirely liquid), is the tool used here.
- IBS-C (constipation-predominant): Most of your abnormal stools are hard or lumpy (Bristol types 1 and 2).
- IBS-D (diarrhea-predominant): Most of your abnormal stools are loose or watery (Bristol types 6 and 7).
- IBS-M (mixed): You frequently swing between both extremes.
- IBS-U (unclassified): Your pattern doesn’t fit neatly into any of the above.
Some gastroenterologists will ask you to keep a stool diary for a couple of weeks, logging each bowel movement’s consistency on the Bristol scale. This gives a clearer picture than trying to recall your pattern from memory during a short appointment.
What Your Doctor Is Ruling Out
Because IBS is identified by its symptoms rather than a definitive biomarker, part of the diagnostic process involves making sure nothing else is causing those symptoms. This doesn’t mean you’ll undergo dozens of tests. Current guidelines from the American College of Gastroenterology recommend against routine colonoscopy in patients under 45 who don’t have red flag symptoms, because the chance of finding something like polyps or inflammatory disease in that group is actually lower than in the general population.
The red flags that do prompt more investigation include rectal bleeding, unexplained weight loss, iron-deficiency anemia, fever, a family history of colon cancer, and symptom onset after age 50. If any of these are present, your doctor will likely order a colonoscopy or additional imaging before settling on an IBS diagnosis.
Celiac Disease Screening
A blood test for celiac disease is one of the few tests recommended for nearly everyone being evaluated for IBS, especially those with the diarrhea-predominant type. Celiac symptoms overlap heavily with IBS, and it’s common enough that screening is considered worthwhile even without classic signs like severe bloating after eating bread.
Fecal Calprotectin
This stool test measures a protein released by inflamed intestinal tissue. It’s one of the most useful tools for distinguishing IBS from inflammatory bowel disease (Crohn’s or ulcerative colitis). A result below 50 micrograms per gram makes IBD very unlikely due to the test’s high sensitivity. A result above that threshold doesn’t confirm IBD on its own, but it signals the need for further workup, usually a colonoscopy with biopsies. For many patients, a normal calprotectin result can spare them from an invasive procedure entirely.
Breath Tests for Overlapping Conditions
If your symptoms don’t respond well to initial treatment, or if bloating and gas are especially prominent, your doctor may order a hydrogen breath test. You drink a solution containing a specific sugar (glucose, lactose, or fructose), then breathe into a collection device at regular intervals. Bacteria in your gut ferment unabsorbed sugars and produce hydrogen gas, which travels through your bloodstream to your lungs, where it can be measured in your breath.
The thresholds vary depending on what’s being tested. A rise of 12 parts per million above your baseline hydrogen level after drinking glucose suggests small intestinal bacterial overgrowth (SIBO). For lactose and fructose malabsorption, the cutoff is higher: 20 ppm above baseline. About 15% to 30% of people have gut bacteria that convert hydrogen into methane, which means their breath hydrogen stays low even when malabsorption is present. Newer breath test devices measure methane alongside hydrogen to catch these cases.
Bile Acid Malabsorption Testing
Up to a third of people initially diagnosed with IBS-D may actually have bile acid malabsorption, a condition where excess bile acids reach the colon and trigger watery diarrhea. Testing for this is more established in Europe, where a nuclear medicine scan called SeHCAT is the standard. That test isn’t available in the United States.
In the U.S., the main option is a 48-hour stool collection that measures total bile acid levels directly. Mayo Clinic uses this approach and can measure both bile acids and fecal fat from the same sample. A blood test measuring a liver enzyme byproduct called 7-alpha-C4 is a less burdensome alternative that’s gaining traction. Identifying bile acid malabsorption matters because it responds to a specific type of medication that standard IBS treatments don’t cover.
Blood Tests for Post-Infectious IBS
A newer blood test measures antibodies linked to post-infectious IBS, the type that develops after a bout of food poisoning or gastroenteritis. The test looks for antibodies against two proteins (CdtB and vinculin) that can damage the nerves controlling gut motility. It’s highly specific, meaning a negative result is reliable about 90% of the time. However, sensitivity is only around 40%, so a positive result isn’t as definitive. This test is most useful for patients with diarrhea-predominant symptoms and a clear history of an infectious trigger, and it can help avoid further unnecessary testing when results are negative.
Why Diagnosis Often Takes Years
Despite having clear diagnostic criteria, the average time from first symptoms to a confirmed IBS diagnosis is over six years. That gap isn’t because the condition is hard to identify. It’s largely because many doctors feel uncomfortable making a “positive” diagnosis based on symptoms alone and instead keep ordering additional procedures to rule out increasingly unlikely conditions. Each round of testing takes time, adds cost, and delays treatment.
The shift in recent guidelines is toward diagnosing IBS based on the Rome IV criteria with only minimal testing, rather than treating it as a diagnosis of exclusion that requires eliminating every other possibility first. If your symptoms clearly match the criteria and you don’t have any red flag signs, a limited set of blood work and possibly a calprotectin test is often enough to start treatment with confidence. Asking your doctor whether your symptoms meet Rome IV criteria directly can sometimes speed this process along.